Management of Elevated Albumin-Creatinine Ratio (ACR)
Initial Assessment and Confirmation
- The American Diabetes Association recommends confirming the elevated ACR by obtaining 2-3 specimens within a 3-6 month period, as there is high biological variability (>20%) between measurements 1
- The American Diabetes Association suggests ruling out transient causes of elevated ACR such as exercise within 24 hours, infection, fever, congestive heart failure, marked hyperglycemia, menstruation, and marked hypertension 2
- The National Kidney Foundation recommends calculating estimated glomerular filtration rate (eGFR) using the CKD-EPI equation to assess kidney function 1
- The International Society of Nephrology recommends evaluating for other markers of kidney damage including urine sediment abnormalities, electrolyte disorders, and structural abnormalities 3
Risk Stratification Based on ACR Categories
- The American Diabetes Association defines A1 (Normal to mildly increased) as ACR <30 mg/g creatinine 4
- The American Diabetes Association defines A2 (Moderately increased) as ACR 30-300 mg/g creatinine (formerly called microalbuminuria) 4
- The American Diabetes Association defines A3 (Severely increased) as ACR >300 mg/g creatinine 4
Management Based on ACR Category and eGFR
- The American Heart Association recommends initiating an ACE inhibitor or angiotensin receptor blocker (ARB) for patients with hypertension and ACR 30-300 mg/g (A2 category) 2
- The American College of Cardiology recommends monitoring serum creatinine and potassium levels periodically when using ACE inhibitors, ARBs, or diuretics 2
- The American Heart Association suggests optimizing blood pressure control with target based on individual risk factors 5
- The Academy of Nutrition and Dietetics recommends implementing lifestyle modifications including dietary sodium restriction, weight management, and physical activity 5
Monitoring Frequency Based on Risk
- The National Kidney Foundation recommends that the frequency of monitoring should be guided by the combined assessment of GFR and albuminuria categories 5
- The American Journal of Kidney Diseases recommends annual monitoring for patients with normal or mildly decreased eGFR and normal ACR 6
- The American Journal of Kidney Diseases recommends monitoring every 6 months for patients with moderately increased ACR (30-300 mg/g) 6
- The American Journal of Kidney Diseases recommends monitoring every 3-6 months for patients with severely increased ACR (>300 mg/g) 6
Criteria for Nephrology Referral
- The American Diabetes Association recommends referral to nephrology for patients with eGFR <30 ml/min/1.73m² 2
- The International Society of Nephrology recommends referral to nephrology for patients with uncertainty about the etiology of kidney disease 2
- The American Journal of Kidney Diseases recommends referral to nephrology for patients with rapidly progressing kidney disease (change in eGFR >20% on subsequent testing) 6
Special Considerations
- The American Diabetes Association recommends annual ACR screening for patients with diabetes, regardless of eGFR 2
- The National Kidney Foundation recommends considering measuring cystatin C to confirm CKD diagnosis for patients with eGFR 45-59 ml/min/1.73m² without other markers of kidney damage 5
- The American Journal of Kidney Diseases recommends evaluation for patients with a doubling of ACR on subsequent testing 6
Long-term Management
- The American Heart Association recommends regular assessment of CKD progression risk factors including cause of CKD, level of GFR, level of albuminuria, age, sex, race/ethnicity, BP, hyperglycemia, dyslipidemia, smoking, obesity, history of cardiovascular disease, and exposure to nephrotoxic agents 5
- The Academy of Nutrition and Dietetics recommends implementing appropriate interventions for modifiable risk factors 5
- The American Journal of Kidney Diseases recommends considering using kidney failure risk prediction tools to guide decisions about timing of preparation for kidney replacement therapy 6